
Zydus Sunshine Lifesciences signed an agreement with Sri Lanka’s Board of Investment to establish a pharmaceutical manufacturing facility in Horana.
The $20 million project spans nearly four acres and aims to commence commercial operations in 2028 subject to regulatory approvals.
The facility will manufacture oral solid dosage forms in its first phase to strengthen local medicine supply chain resilience and enhance Zydus's international presence.